KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

News: KZA Kazia Therapeutics Launches New Paxalisib Phase Ii Clinical Trial

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    15/06/21
    11:50
    Post #: 53845838

    June 15 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • KAZIA THERAPEUTICS LTD - KAZIA LAUNCHES NEW PAXALISIB PHASE II CLINICAL TRIAL-KZA.AX
    • KAZIA THERAPEUTICS - ENTERED COLLABORATION WITH JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY IN UNITED STATES
    • KAZIA THERAPEUTICS - COLLABORATION TO LAUNCH PHASE II CLINICAL STUDY OF CO'S NEW DRUG, PAXALISIB, IN COMBINATION WITH KETOGENESIS, FOR GLIOBLASTOMA
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Strong soil results define new gold targets at Tole and Dadjan
right-arrow Created with Sketch.
NEWS New channel sampling confirms further copper at Graceland, Namibia
right-arrow Created with Sketch.
NEWS Marquee declares maiden antimony resource at Eastern Hills with phase two exploration to commence
right-arrow Created with Sketch.
NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
NEWS View the latest ASX market news here
right-arrow Created with Sketch.
NEWS Askari sells Burracoppin Gold Project to Forrestania Resources
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.